analyst
CL
NASDAQ · CLDX
Celldex Therapeutics, Inc.
Healthcare · Biotechnology
$31.65
Down-$0.53 (-1.65%)
Updated Oct 4, 2026, 8:33 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.86B
- P/E ratio
- -9.3
- Dividend yield
- 0.00%
- 52-week range
- $27.92 – $45.14
- Volume
- 2.41M
- Avg. volume
- 937.83K
Price performance · CLDX
CLDX price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
CLDX closed at $31.65 after 19 trading sessions, down 19.10% for the selected period.
- Last close
- $31.65
- Period change
- -19.10%
- Period low
- $31.10
- Period high
- $39.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $32.26 | $32.54 | $30.98 | $31.65 | 2.41M |
| Oct 1, 2026 | $32.26 | $32.55 | $31.7016 | $32.18 | 1.44M |
| Sep 30, 2026 | $31.71 | $32.76 | $31.45 | $32.41 | 2.5M |
| Sep 29, 2026 | $31.49 | $31.79 | $30.995 | $31.64 | 2.03M |
| Sep 28, 2026 | $31.06 | $32.15 | $30.38 | $31.49 | 1.82M |
| Sep 25, 2026 | $31.48 | $31.705 | $30.65 | $31.10 | 2.02M |
| Sep 24, 2026 | $31.48 | $31.66 | $30.594 | $31.48 | 2.3M |
| Sep 23, 2026 | $33.54 | $33.59 | $30.405 | $31.12 | 4.24M |
| Sep 22, 2026 | $36.60 | $38.39 | $30.39 | $33.51 | 12.89M |
| Sep 21, 2026 | $41.62 | $41.62 | $37.48 | $37.89 | 549.51K |
| Sep 18, 2026 | $38.87 | $38.87 | $37.535 | $38.24 | 2.08M |
| Sep 17, 2026 | $39.47 | $40.66 | $38.92 | $38.98 | 1.28M |
| Sep 16, 2026 | $38.59 | $39.21 | $38.25 | $38.71 | 1M |
| Sep 15, 2026 | $39.00 | $39.19 | $37.74 | $38.51 | 686.39K |
| Sep 14, 2026 | $37.40 | $39.42 | $37.27 | $39.18 | 1M |
| Sep 11, 2026 | $38.39 | $38.59 | $36.84 | $36.90 | 1.03M |
| Sep 10, 2026 | $38.78 | $38.86 | $37.75 | $38.10 | 949.01K |
| Sep 9, 2026 | $38.95 | $40.035 | $38.67 | $38.78 | 588.42K |
| Sep 8, 2026 | $38.78 | $39.865 | $38.50 | $39.12 | 834.31K |
Latest CLDX news
The latest Smart Investors Daily articles mentioning CLDX.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News
Loading stock research…